Maropitant Citrate Tablets for Dogs

Not for use in humans. Keep out of the reach of children. In case of accidental ingestion, seek medical advice. Topical exposure may elicit localized allergic skin reactions in some individuals. Repeated or prolonged exposure may lead to skin sensitization. Wash hands with soap and water after administering drug. Maropitant Citrate is also an ocular irritant. In case of accidental eye exposure, flush with water for 15 minutes and seek medical attention. Keep Maropitant Citrate Tablets in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. In puppies younger than 11 weeks of age, histological evidence of bone marrow hypocellularity was observed at higher frequency and greater severity in puppies treated with Maropitant Citrate compared to control puppies. In puppies 16 weeks and older, bone marrow hypocellularity was not observed (see ANIMAL SAFETY). PRECAUTIONS: The safe use of Maropitant Citrate tablets has not been evaluated in dogs used for breeding, or in pregnant or lactating bitches. The safe use of Maropitant Citrate has not been evaluated in dogs with gastrointestinal obstruction, or dogs that have ingested toxins. Use with caution in dogs with hepatic dysfunction because Maropitant Citrate is metabolized by CYP3A enzymes (see Pharmacokinetics).Use with caution with other medications that are highly protein bound. The concomitant use of Maropitant Citrate with other protein bound drugs has not been studied in dogs. Commonly used protein bound drugs include NSAIDs, cardiac, anticonvulsant, and behavioral medications.